CS267192A3 - Expression systems - Google Patents

Expression systems Download PDF

Info

Publication number
CS267192A3
CS267192A3 CS922671A CS267192A CS267192A3 CS 267192 A3 CS267192 A3 CS 267192A3 CS 922671 A CS922671 A CS 922671A CS 267192 A CS267192 A CS 267192A CS 267192 A3 CS267192 A3 CS 267192A3
Authority
CS
Czechoslovakia
Prior art keywords
vector
expression
cells
polypeptide
hgh
Prior art date
Application number
CS922671A
Other languages
Czech (cs)
English (en)
Inventor
Melvyn Hollis
Maurice Ronald Charles Needham
Clare Gooding
Franklin Geradus Grosveld
Michael Antoniou
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of CS267192A3 publication Critical patent/CS267192A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Massaging Devices (AREA)
  • Cephalosporin Compounds (AREA)
CS922671A 1990-12-21 1992-08-28 Expression systems CS267192A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909027917A GB9027917D0 (en) 1990-12-21 1990-12-21 Expression systems
PCT/GB1991/002274 WO1992011380A1 (en) 1990-12-21 1991-12-19 Expression systems

Publications (1)

Publication Number Publication Date
CS267192A3 true CS267192A3 (en) 1992-12-16

Family

ID=10687512

Family Applications (1)

Application Number Title Priority Date Filing Date
CS922671A CS267192A3 (en) 1990-12-21 1992-08-28 Expression systems

Country Status (18)

Country Link
US (1) US5538885A (de)
EP (1) EP0516787B1 (de)
JP (1) JP3148237B2 (de)
KR (1) KR920703830A (de)
AT (1) ATE196653T1 (de)
AU (1) AU660636B2 (de)
CA (1) CA2058280A1 (de)
CS (1) CS267192A3 (de)
DE (1) DE69132429T2 (de)
FI (1) FI923758A0 (de)
GB (2) GB9027917D0 (de)
HU (1) HUT66062A (de)
IE (1) IE914497A1 (de)
IL (1) IL100413A0 (de)
NZ (1) NZ241045A (de)
PL (1) PL295798A1 (de)
WO (1) WO1992011380A1 (de)
ZA (1) ZA9110015B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627268A (en) * 1994-06-07 1997-05-06 Dnx Biotherapeutics Hemoglobin comprising globin fusion proteins
US5821351A (en) * 1994-06-10 1998-10-13 Dnx Biotherapeutics Production of hemoglobin having a delta-like globin
GB9505777D0 (en) * 1995-03-22 1995-05-10 Zeneca Ltd Process
DE69704206T2 (de) * 1996-08-16 2001-08-30 Medical Research Council, London Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
US6284496B1 (en) 1997-10-03 2001-09-04 University Of South Florida DNA vector for determining the presence of out-of-reading-frame mutations
DE69927812D1 (de) * 1998-06-08 2005-11-24 Acgt Medico Inc Erkennung von dns, rns und proteinen
GB9910664D0 (en) * 1999-05-07 1999-07-07 Zeneca Ltd Cells and assay
US6645745B1 (en) * 2000-05-30 2003-11-11 Epidauros Biotechnologie Ag Identification of a new member of the cytochrome P450 3A (CYP3A) gene family: CYP3AX
US7033806B2 (en) * 2000-06-08 2006-04-25 The Regents Of The University Of California HY2 family of bilin reductases
AU2002306764A1 (en) * 2001-03-19 2002-10-03 Cargill Incorporated Myo-inositol oxygenases
US6887688B2 (en) * 2001-05-29 2005-05-03 The Regents Of The University Of California Light controlled gene expression utilizing heterologous phytochromes
WO2004005464A2 (en) * 2002-07-02 2004-01-15 Uab Research Foundation Compounds promoting delivery of genes
US7795397B2 (en) * 2004-05-06 2010-09-14 The Regents Of The University Of California Red and near infrared flourescent phyotochrome
CN107106689A (zh) 2014-11-05 2017-08-29 沃雅戈治疗公司 用于治疗帕金森病的aadc多核苷酸
CN110650673B (zh) 2016-08-30 2024-04-09 加利福尼亚大学董事会 用于生物医学靶向和递送的方法以及用于实践该方法的装置和系统
JOP20190269A1 (ar) 2017-06-15 2019-11-20 Voyager Therapeutics Inc بولي نوكليوتيدات aadc لعلاج مرض باركنسون
JP7229989B2 (ja) 2017-07-17 2023-02-28 ボイジャー セラピューティクス インコーポレイテッド 軌道アレイガイドシステム
EP3794126A1 (de) 2018-05-15 2021-03-24 Voyager Therapeutics, Inc. Zusammensetzungen und verfahren zur behandlung von morbus parkinson

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663281A (en) * 1984-03-22 1987-05-05 Mass Institute Of Technology Enhanced production of proteinaceous materials in eucaryotic cells
CA1297435C (en) * 1986-09-12 1992-03-17 Stephen D. Gillies Messenger rna stabilization in animal cells
GB2197321B (en) * 1986-09-12 1990-10-03 Genentech Inc Method and vectors for obtaining continuous production of heterologous protein in a eukaryotic host cell line
GB8718779D0 (en) * 1987-08-07 1987-09-16 Grosveld F G Dna sequence & expression vector
EP0377676B1 (de) * 1987-09-17 1995-05-24 Massachusetts Institute Of Technology Menschliche, erythroid-spezifische transkriptionsenhancer
GB8904009D0 (en) * 1989-02-22 1989-04-05 Celltech Ltd Vector
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
WO1991005041A1 (en) * 1989-09-26 1991-04-18 Townes Tim M Erythroid-specific gene expression system
WO1991013151A1 (en) * 1990-02-22 1991-09-05 Biogen, Inc. Improved expression of polypeptides

Also Published As

Publication number Publication date
NZ241045A (en) 1994-11-25
AU660636B2 (en) 1995-07-06
WO1992011380A1 (en) 1992-07-09
ZA9110015B (en) 1992-10-28
GB2251622A (en) 1992-07-15
KR920703830A (ko) 1992-12-18
DE69132429T2 (de) 2001-03-01
IE914497A1 (en) 1992-07-01
CA2058280A1 (en) 1992-06-22
HU9202458D0 (en) 1992-10-28
EP0516787A1 (de) 1992-12-09
ATE196653T1 (de) 2000-10-15
FI923758L (fi) 1992-08-20
JP3148237B2 (ja) 2001-03-19
FI923758A7 (fi) 1992-08-20
AU9096891A (en) 1992-07-22
GB9126984D0 (en) 1992-02-19
US5538885A (en) 1996-07-23
FI923758A0 (fi) 1992-08-20
JPH05504261A (ja) 1993-07-08
GB9027917D0 (en) 1991-02-13
HUT66062A (en) 1994-09-28
IL100413A0 (en) 1992-09-06
PL295798A1 (en) 1993-07-12
GB2251622B (en) 1995-05-03
DE69132429D1 (de) 2000-11-02
EP0516787B1 (de) 2000-09-27

Similar Documents

Publication Publication Date Title
EP0920498B1 (de) Ef-1-alpha transkriptionsregulatorische dna aus hamster
KR100379356B1 (ko) 상동재조합을달성하기위한dna구성물및이것의용도
AU692196B2 (en) Translational enhancer DNA
JP3148237B2 (ja) 形質転換されたマウス赤白血病細胞
CN114502731A (zh) 基于转座子的免疫细胞的修饰
KR20150123803A (ko) 향상된 이식유전자 발현 및 가공
CN111163633A (zh) 包含人源化ttr基因座的非人类动物及其使用方法
BG60624B1 (bg) Ендогенна модификация на генната експресия чрез регулаторен елемент
JP2002542781A (ja) Ｐ因子由来ベクター及びその使用法
WO2002048379A1 (en) Expression vector for animal cell containing nuclear matrix attachment region fo interferon beta
CN113874510A (zh) 包括具有β滑移突变的人源化TTR基因座的非人动物和使用方法
EP0471832A1 (de) Verbesserte expression von polypeptiden
JP2010522549A (ja) 目的のポリヌクレオチドの発現を増強するためのポリヌクレオチド
KR101033819B1 (ko) 돼지의 베타 카제인 유전자, 그 프로모터 및 그의 용도
Gunaratne et al. An evolutionarily conserved palindrome in the Drosophila Gld promoter directs tissue-specific expression.
CZ160198A3 (cs) Transgenní zvíře, transgen, způsob jejich přípravy a použití pro purifikaci transkripčních komplexů
CA3200855A1 (en) Influenza a-resistant animals having edited anp32 genes
HK1022719B (en) HAMSTER EF-1α TRANSCRIPTIONAL REGULATORY DNA
HK1138320A (en) Hamster ef-1 alpha transcriptional regulation dna
JPH11318468A (ja) 脳神経組織細胞の分化に関わる新規なタンパク質
JPWO2001025425A1 (ja) 核局在性ＲｅｃＱ５型ＤＮＡヘリカーゼ